Buscopan isn’t technically banned in the United States. It was never approved by the FDA for human use, which effectively makes it unavailable through American pharmacies and hospitals. The distinction matters: a ban implies the drug was pulled for safety reasons, but in this case, no manufacturer has successfully brought it through the FDA’s approval process for people. The only FDA-approved form of Buscopan in the U.S. is a veterinary injectable, authorized since 2004 as an antispasmodic for horses.
Why It Was Never FDA-Approved
The active ingredient in Buscopan is hyoscine butylbromide, an antispasmodic that relaxes smooth muscle in the digestive tract. It’s sold over the counter in dozens of countries, including the UK, Australia, Canada, and throughout Europe, where it’s commonly used for stomach cramps, irritable bowel syndrome, and menstrual pain. Despite this widespread global availability, no pharmaceutical company has submitted and completed the necessary application to market it for human use in the U.S.
Getting a drug approved by the FDA requires a formal New Drug Application backed by clinical trials conducted to FDA standards. This process costs hundreds of millions of dollars and can take years. For a company to invest that kind of money, the potential return needs to justify it. Because several similar antispasmodic drugs already exist on the American market, there’s little financial incentive for a manufacturer to pursue approval for hyoscine butylbromide specifically. The U.S. market is already covered by alternatives, so the gap that Buscopan fills elsewhere simply doesn’t exist here from a business perspective.
What Americans Use Instead
The U.S. has its own FDA-approved antispasmodics that work through similar pathways. The most direct substitute is hyoscyamine, sold under brand names like Levsin, Anaspaz, and Cystospaz. Hyoscyamine relaxes the muscles in the digestive tract and bladder while also reducing stomach acid, sweat, and saliva production. It’s prescribed for irritable bowel syndrome, stomach ulcers, and bladder spasms.
Hyoscyamine and hyoscine butylbromide are chemically related but not identical. One key difference is that hyoscine butylbromide doesn’t easily cross into the brain, which means it causes fewer central nervous system side effects like drowsiness or confusion. Hyoscyamine can cross that barrier, so it sometimes produces those effects. For many American patients, though, the available alternatives work well enough that the absence of Buscopan from pharmacy shelves goes unnoticed.
Dicyclomine (Bentyl) is another commonly prescribed option in the U.S. for intestinal cramping and IBS symptoms. It works through the same general mechanism of relaxing gut muscles.
Is Buscopan Dangerous?
Buscopan’s absence from the U.S. market isn’t a reflection of unusual danger. In oral tablet form, it has a well-established safety profile across decades of global use. Common side effects are mild: dry mouth, blurred vision, and occasionally a faster heart rate.
The injectable form does carry more significant risks. The UK’s medicines safety agency has issued warnings that hyoscine butylbromide injections can cause rapid heart rate, dangerously low blood pressure, and severe allergic reactions. These effects can be fatal in patients with underlying heart disease, including heart failure, coronary artery disease, and arrhythmias. The injection is contraindicated in patients who already have a fast heart rate. These concerns apply to the intravenous form used in clinical settings, not the oral tablets that most people associate with the Buscopan name.
Can You Bring Buscopan Into the U.S.?
Technically, importing any drug that lacks FDA approval is illegal. The FDA states clearly that products purchased from other countries that haven’t been approved for U.S. sale are generally not permitted entry. That said, the agency does exercise discretion in certain situations. FDA personnel may allow a small quantity through if the product isn’t for a serious condition and poses no known significant health risk, or if it’s a continuation of treatment started in another country.
In practice, travelers who bring back a box of Buscopan tablets from a trip abroad are unlikely to face enforcement action. The FDA’s discretionary guidelines suggest that a quantity of three months’ supply or less, intended for personal use, may be permitted. You’d need to be able to affirm the product is for your own use, and ideally have the name of a U.S.-licensed doctor overseeing your care. Ordering Buscopan online from international pharmacies is riskier from a legal standpoint and also raises concerns about product authenticity.
The Bottom Line on Availability
The situation with Buscopan is less dramatic than the word “banned” suggests. It’s a gap in the market created by regulatory economics, not a safety prohibition. Millions of people use it safely worldwide, and the FDA hasn’t flagged it as a dangerous substance. The reality is simply that no company has found it worthwhile to spend the money needed to bring it through the American approval process when similar drugs already have that approval. If you’ve used Buscopan while traveling and want something comparable at home, a doctor can prescribe one of the existing U.S. antispasmodics that target the same type of muscle cramping.